Sunzen Biotech rights issue oversubscribed 14%


Sunzen chief executive officer Jim Hong

Sunzen chief executive officer Jim Hong said the oversubscription demonstrated confidence in the group's plans to continue leading in the development, manufacture and market of safe and quality animal health care products across Malaysia and abroad. 

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

   

Next In Business News

Eupe fourth-quarter profit rises 29%
Meta projects higher spending, weaker revenue
Buyout proposal for Anglo American could reshape copper market
A test bed for airline subscription model
Pantech seeks to list steel pipe units
AI memory boom propels SK Hynix’s numbers
Battery stocks’ rally in India likely to extend
Congo accuses Apple of using ‘blood minerals’ from war-torn east
Airlines must now provide automatic refunds for cancelled flights
Boeing CEO upbeat on cash goal, quality review

Others Also Read